Diabetes - Perspectives in Drug Therapy [electronic resource] / edited by Mathias Schwanstecher.

Por: Schwanstecher, Mathias [editor.]Tipo de material: TextoTextoSeries Handbook of Experimental Pharmacology, 203Editor: Berlin, Heidelberg : Springer Berlin Heidelberg : Imprint: Springer, 2011Descripción: XIII, 408 p. 69 illus. online resourceTipo de contenido: text Tipo de medio: computer Tipo de portador: online resourceISBN: 9783642172144Trabajos contenidos: SpringerLink (Online service)Tema(s): Medicine | Human physiology | Toxicology | Internal medicine | Cytology | Biomedicine | Pharmacology/Toxicology | Human Physiology | Cell Biology | Internal Medicine | Molecular MedicineFormatos físicos adicionales: Sin títuloClasificación CDD: 615 Clasificación LoC:RM1-950Recursos en línea: de clik aquí para ver el libro electrónico Springer eBooksResumen: Every 5 seconds someone somewhere is diagnosed with diabetes, and every 10 seconds someone dies of it. Even worse, worldwide incidence rates still inexorably escalate. Thus, it is pressing to envisage the extent of the diabetes problem and ensure synergistic approaches aiming in alleviation of its ghastly toll. The chapters of this book report cutting-edge research on molecular events in adiposity and type 2 diabetes, thus opening the way for innovative drug-based therapeutic strategies. It addresses all those who wish to keep in touch with recent developments in the field.
Etiquetas de esta biblioteca: No hay etiquetas de esta biblioteca para este título. Ingresar para agregar etiquetas.
    Valoración media: 0.0 (0 votos)
No hay ítems correspondientes a este registro

Every 5 seconds someone somewhere is diagnosed with diabetes, and every 10 seconds someone dies of it. Even worse, worldwide incidence rates still inexorably escalate. Thus, it is pressing to envisage the extent of the diabetes problem and ensure synergistic approaches aiming in alleviation of its ghastly toll. The chapters of this book report cutting-edge research on molecular events in adiposity and type 2 diabetes, thus opening the way for innovative drug-based therapeutic strategies. It addresses all those who wish to keep in touch with recent developments in the field.

ZDB-2-SBL

No hay comentarios en este titulo.

para colocar un comentario.